Profit Taking Sinks Arena

Investors locked in profits on Arena Pharmaceuticals Inc. (Nasdaq: ARNA), whose stock price climbed the last two days after announcing that European regulators accepted the marketing application for its weight loss treatment Lorcaserin. Shares of the biopharmaceutical lost 34 cents to close at $2.92.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here